Definiens' Biomarker Datafication Services for Oncology

Definiens has launched a suite of biomarker datafication services for oncology clinical development programs. These services will enable pharmaceutical and biotech companies gather comprehensive data from tissue samples that they can use to make decisions about which drug candidates to advance as well as assess the potential of companion diagnostics for patient stratification. Through the service, users gain access to data such as biomarker expression profiles, biological response to therapy and continuous biomarker readouts enabling advanced decision making and data analysis.